Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute?Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.

Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute?Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial. JACC Cardiovasc Interv. 2016 09 26; 9(18):1905-13.

View in: PubMed

subject areas

Acute Coronary Syndrome
Adenosine Monophosphate
Aged
Angina, Stable
Chi-Square Distribution
Coronary Thrombosis
Double-Blind Method
Female
Hemorrhage
Humans
Logistic Models
Male
Middle Aged
Myocardial Infarction
Odds Ratio
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Risk Factors
Ticlopidine
Time Factors
Treatment Outcome

authors with profiles

Robert Harrington